LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)
$18.64 -0.55 (-2.8661%)
Analysed LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) News Sources
Legend Biotech Q2 Earnings Call Highlights
11-08-2026
marketbeat.com
Legend Biotech shares rise 5% as Q2 earnings and revenue beat estimates
11-08-2026
advfn.com
Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus
11-08-2026
247wallst.com
Legend Biotech Corp (LEGN) (Q2 2026) Earnings Call Highlights: First Profitable Quarter Driven ...
11-08-2026
yahoo.com
Legend Biotech (LEGN) Q2 2026 Earnings Call Transcript
12-08-2026
fool.com
Sector Update: Healthcare Stocks Advance Late Afternoon
12-08-2026
yahoo.com
The hidden scale-out problem behind CAR-T’s growth
01-09-2026
pharmavoice.com
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
01-09-2026
yahoo.com
Legend Biotech (LEGN) Stock May Be Undervalued Despite A 70% 3 Year Fall
01-09-2026
yahoo.com
Legend Biotech (LEGN) Heads To Morgan Stanley Conference, Is The 57% Valuation Gap Justified?
02-09-2026
yahoo.com
What is the current price of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)?
The current price of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) is $18.64.
LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) since the previous trading day is $-0.55.
LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) since the previous trading day is -2.8661%.
What is the most recent average sentiment score for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)?
The most recent average sentiment score for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)?
The most recent sentiment for LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ) is .
SEC-8K** Filing Available For LEGEND BIOTECH CORP-ADR (LEGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.